carbamazepine has been researched along with Extramembranous Glomerulopathy in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 22-year-old male with Fabry disease presented with proteinuria during ERT with agalsidase-β and carbamazepine." | 8.12 | Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report. ( Aoyagi, J; Ito, T; Kanai, T; Yamagata, T, 2022) |
| "A 22-year-old male with Fabry disease presented with proteinuria during ERT with agalsidase-β and carbamazepine." | 4.12 | Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report. ( Aoyagi, J; Ito, T; Kanai, T; Yamagata, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, T | 1 |
| Ito, T | 1 |
| Aoyagi, J | 1 |
| Yamagata, T | 1 |
1 other study available for carbamazepine and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report.
Topics: Adult; Carbamazepine; Enzyme Replacement Therapy; Fabry Disease; Glomerulonephritis, Membranous; Hum | 2022 |